Stock DNA
Pharmaceuticals & Biotechnology
PLN 5,185 Million (Mid Cap)
28.00
NA
0.00%
1.45
-999,999.00%
10.47
Revenue and Profits:
Net Sales:
618 Million
(Quarterly Results - Dec 2025)
Net Profit:
39 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.81%
0%
-11.81%
6 Months
-11.9%
0%
-11.9%
1 Year
-8.01%
0%
-8.01%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Diagnostyka SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.90%
EBIT Growth (5y)
-22.41%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
50.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
12.54
EV to EBIT
21.68
EV to EBITDA
14.40
EV to Capital Employed
5.71
EV to Sales
3.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.35%
ROE (Latest)
44.59%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
618.30
612.30
0.98%
Operating Profit (PBDIT) excl Other Income
123.70
150.30
-17.70%
Interest
18.50
17.10
8.19%
Exceptional Items
-0.20
0.00
Consolidate Net Profit
39.30
80.70
-51.30%
Operating Profit Margin (Excl OI)
114.20%
161.40%
-4.72%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 0.98% vs 4.08% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -51.30% vs 20.81% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,410.50
1,950.10
23.61%
Operating Profit (PBDIT) excl Other Income
580.90
481.00
20.77%
Interest
68.10
56.30
20.96%
Exceptional Items
-6.70
14.00
-147.86%
Consolidate Net Profit
261.90
232.00
12.89%
Operating Profit Margin (Excl OI)
157.30%
163.80%
-0.65%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 23.61% vs 22.80% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 12.89% vs 78.46% in Dec 2024






